Ameritas Investment Partners’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,656
| Closed | -$4.81K | – | 3273 |
|
|
2025
Q1 | $4.81K | Hold |
10,656
| – | – | ﹤0.01% | 2978 |
|
|
2024
Q4 | $5.36K | Hold |
10,656
| – | – | ﹤0.01% | 3017 |
|
|
2024
Q3 | $9.65K | Hold |
10,656
| – | – | ﹤0.01% | 2934 |
|
|
2024
Q2 | $10.6K | Hold |
10,656
| – | – | ﹤0.01% | 2900 |
|
|
2024
Q1 | $15.8K | Hold |
10,656
| – | – | ﹤0.01% | 2664 |
|
|
2023
Q4 | $11.6K | Hold |
10,656
| – | – | ﹤0.01% | 2799 |
|
|
2023
Q3 | $12.6K | Hold |
10,656
| – | – | ﹤0.01% | 2730 |
|
|
2023
Q2 | $15K | Buy |
+10,656
| New | +$15K | ﹤0.01% | 2713 |
|
|
2022
Q2 | – | Sell |
-9,508
| Closed | -$15K | – | 3159 |
|
|
2022
Q1 | $15K | Hold |
9,508
| – | – | ﹤0.01% | 2668 |
|
|
2021
Q4 | $23K | Hold |
9,508
| – | – | ﹤0.01% | 2576 |
|
|
2021
Q3 | $24K | Hold |
9,508
| – | – | ﹤0.01% | 2601 |
|
|
2021
Q2 | $27K | Buy |
+9,508
| New | +$27K | ﹤0.01% | 2568 |
|
|
2020
Q2 | – | Sell |
-6,005
| Closed | -$5K | – | 3100 |
|
|
2020
Q1 | $5K | Hold |
6,005
| – | – | ﹤0.01% | 2814 |
|
|
2019
Q4 | $5K | Hold |
6,005
| – | – | ﹤0.01% | 2901 |
|
|
2019
Q3 | $6K | Hold |
6,005
| – | – | ﹤0.01% | 2894 |
|
|
2019
Q2 | $7K | Hold |
6,005
| – | – | ﹤0.01% | 2886 |
|
|
2019
Q1 | $8K | Hold |
6,005
| – | – | ﹤0.01% | 2764 |
|
|
2018
Q4 | $5K | Sell |
6,005
-859
| -13% | -$715 | ﹤0.01% | 2858 |
|
|
2018
Q3 | $14K | Hold |
6,864
| – | – | ﹤0.01% | 2692 |
|
|
2018
Q2 | $12K | Hold |
6,864
| – | – | ﹤0.01% | 2780 |
|
|
2018
Q1 | $16K | Hold |
6,864
| – | – | ﹤0.01% | 2526 |
|
|
2017
Q4 | $13K | Hold |
6,864
| – | – | ﹤0.01% | 2658 |
|
|
2017
Q3 | $17K | Hold |
6,864
| – | – | ﹤0.01% | 2518 |
|
|
2017
Q2 | $19K | Hold |
6,864
| – | – | ﹤0.01% | 2487 |
|
|
2017
Q1 | $21K | Buy |
+6,864
| New | +$21K | ﹤0.01% | 2375 |
|